CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...
14hon MSN
Q4 2024 Management View CEO David Joyner highlighted the company's Q4 adjusted EPS of $1.19 and adjusted operating income of $2.7 billion. He introduced 2025 adjusted EPS guidance of $5.75 to $6.00, ...
Sees FY25 free cash flow $6.5B. The company said, “The Company issued its full-year 2025 GAAP diluted EPS guidance range of $4.58 to $4.83 and ...
Zacks.com on MSN18h
CVS Health (CVS) Tops Q4 Earnings and Revenue EstimatesCVS Health (CVS) delivered earnings and revenue surprises of 33.71% and 0.67%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
CVS Health’s revenues increased 4.2% in both the quarter and year, compared to the prior year driven by growth in the health care benefits and pharmacy and consumer wellness segments.
Reports Q4 revenue $97.7B, consensus $96.88B. The company said, “Our integrated model allows us to uniquely deliver a simpler, connected ...
U.S. stock futures are little changed as investors watch for January inflation data, and Fed Chair Jerome Powell is set to ...
CVS Health reported Q4 2024 profits of $1.6 billion, down from $2 billion, with annual profits at $4.6 billion, down $8.3 billion in 2023.
Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall ...
Walgreens’s recent dividend suspension and CVS's dividend freeze reflect financial headwinds and operational challenges. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback